多中心双盲随机对照试验:激光辅助孵化对反复种植失败患者行IVF或ICSI的疗效
这项多中心双盲随机对照优效性试验纳入588对反复种植失败的不孕夫妇,比较激光辅助孵化与对照组的累积活产率。辅助孵化组活产77例(25.9%),对照组68例(23.1%),差异无统计学意义(RR 1.125,95%CI 0.847-1.494,P=0.416)。作者建议仅在不额外收费、提供无效证据信息且最好在临床试验中考虑成本效果的情况下提供辅助孵化。
要点
- 辅助孵化组累积活产率25.9%(77/297),对照组23.1%(68/295),差异无统计学意义。
- 相对危险度1.125(95%CI 0.847-1.494,P=0.416),未显示辅助孵化增加活产。
- 作者建议仅在提供无效证据信息、不额外收费且最好在临床试验中提供辅助孵化。
核心结论
- 本研究显示,在反复种植失败的不孕夫妇中,辅助孵化作为附加治疗未显示增加累积活产率的证据。
研究设计与样本
- 研究为双盲、多中心随机对照优效性试验,为证明辅助孵化后活产率绝对增加10%有统计学意义,每治疗组需纳入294例,共588对不孕夫妇。
- 2012年11月至2017年11月纳入并随机分组,辅助孵化组297例,对照组295例,采用区组大小为20的区组随机化。
- 随机化对参与者、治疗医师和参与胚胎移植的实验室人员设盲。
- 研究在荷兰三家三级转诊医院和两家大学医学中心的实验室进行。
- 纳入标准为至少两次连续新鲜IVF或ICSI胚胎移植(包括来自这些新鲜周期的冻融胚胎移植)未获妊娠,或至少一次新鲜IVF或ICSI移植及至少两次来自该新鲜周期的冻融胚胎移植未获妊娠。
主要发现
- 每启动周期的累积活产率(包括新鲜胚胎移植及后续冻融胚胎移植)辅助孵化组为25.9%(77/297),对照组为23.1%(68/295)。
- 相对危险度为1.125(95%CI 0.847-1.494,P=0.416),差异无统计学意义。
关键数值与推荐
- 辅助孵化组累积活产77例(25.9%),对照组68例(23.1%),相对危险度1.125(95%CI 0.847-1.494,P=0.416)。
临床怎么用
- 作者建议,辅助孵化仅应在提供无效证据信息、不额外收费且最好在考虑成本效果的临床试验中提供。
局限性
- 试验终点(末次随机化后1年)时,一小队列不孕夫妇在未获持续妊娠后仍有冷冻保存的胚胎,不能排除未来移植这些冻融胚胎会增加任一或两个研究组的累积活产率。
- 研究开始时反复种植失败的定义尚无国际共识,因此不能排除辅助孵化对更高次数反复种植失败可能有效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Does assisted hatching increase the cumulative live birth rate in subfertile couples with repeated implantation failure? SUMMARY ANSWER: This study showed no evidence of effect for assisted hatching as an add-on in subfertile couples with repeated implantation failure. WHAT IS KNOWN ALREADY: The efficacy of assisted hatching, with regard to the live birth rate has not been convincingly demonstrated in randomized trials nor meta-analyses. It is suggested though that especially poor prognosis women, e.g. women with repeated implantation failure, might benefit most from assisted hatching. STUDY DESIGN, SIZE, DURATION: The study was designed as a double-blinded, multicentre randomized controlled superiority trial. In order to demonstrate a statistically significant absolute increase in live birth rate of 10% after assisted hatching, 294 participants needed to be included per treatment arm, being a total of 588 subfertile couples. Participants were included and randomized from November 2012 until November 2017, 297 were allocated to the assisted hatching arm of the study and 295 to the control arm. Block randomization in blocks of 20 participants was applied and randomization was concealed from participants, treating physicians, and laboratory staff involved in the embryo transfer procedure. Ovarian hyperstimulation, oocyte retrieval, laboratory procedures, embryo selection for transfer and cryopreservation, the transfer itself, and luteal support were performed according to local protocols and were identical in both the intervention and control arm of the study with the exception of the assisted hatching procedure which was only performed in the intervention group. The laboratory staff performing the assisted hatching procedure was not involved in the embryo transfer itself. PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were eligible for inclusion in the study after having had either at least two consecutive fresh IVF or ICSI embryo transfers, including the transfer of frozen and thawed embryos originating from those fresh cycles, and which did not result in a pregnancy or as having had at least one fresh IVF or ICSI transfer and at least two frozen embryo transfers with embryos originating from that fresh cycle which did not result in a pregnancy. The study was performed at the laboratory sites of three tertiary referral hospitals and two university medical centres in the Netherlands. MAIN RESULTS AND THE ROLE OF CHANCE: The cumulative live birth rate per started cycle, including the transfer of fresh and subsequent frozen/thawed embryos if applicable, resulted in 77 live births in the assisted hatching group (n = 297, 25.9%) and 68 live births in the control group (n = 295, 23.1%). This proved to be statistically not significantly different (relative risk: 1.125, 95% CI: 0.847 to 1.494, P = 0.416). LIMITATIONS, REASONS FOR CAUTION: There was a small cohort of subfertile couples that after not achieving an ongoing pregnancy, still had cryopreserved embryos in storage at the endpoint of the trial, i.e. 1 year after the last randomization. It cannot be excluded that the future transfer of these frozen/thawed embryos increases the cumulative live birth rate in either or both study arms. Next, at the start of this study, there was no international consensus on the definition of repeated implantation failure. Therefore, it cannot be excluded that assisted hatching might be effective in higher order repeated implantation failures. WIDER IMPLICATIONS OF THE FINDINGS: This study demonstrated no evidence of a statistically significant effect for assisted hatching by increasing live birth rates in subfertile couples with repeated implantation failure, i.e. the couples which, based on meta-analyses, are suggested to benefit most from assisted hatching. It is therefore suggested that assisted hatching should only be offered if information on the absence of evidence of effect is provided, at no extra costs and preferably only in the setting of a clinical trial taking cost-effectiveness into account. STUDY FUNDING/COMPETING INTEREST(S): None. TRIAL REGISTRATION NUMBER: Netherlands Trial Register (NTR 3387, NL 3235, https://www.clinicaltrialregister.nl/nl/trial/26138). TRIAL REGISTRATION DATE: 6 April 2012. DATE OF FIRST PATIENT’S ENROLMENT: 28 November 2012.
引用
- Curfs MHJM, Cohlen BJ, Slappendel EJ, et al. A multicentre double-blinded randomized controlled trial on the efficacy of laser-assisted hatching in patients with repeated implantation failure undergoing IVF or ICSI. Hum Reprod. 2023. PMID: 37646072. doi:10.1093/humrep/dead173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。